| Ident. | Authors (with country if any) | Title |
|---|
| 000066 (2017) |
Jordan Debono [Australie] ; Bing Xie [République populaire de Chine] ; Aude Violette [Belgique] ; Rudy Fourmy [Belgique] ; Marc Jaeger [France] ; Bryan G. Fry [Australie] | Viper Venom Botox: The Molecular Origin and Evolution of the Waglerin Peptides Used in Anti-Wrinkle Skin Cream. |
| 000486 (2017) |
Mark C. Gillies [Australie] ; Vincent Daien [France] ; Vuong Nguyen [Australie] ; Daniel Barthelmes [Suisse] | Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761). |
| 000636 (2017) |
Bart Spronck [Pays-Bas] ; Tammo Delhaas [Pays-Bas] ; Anouk Gw De Lepper [Pays-Bas] ; Julie Giroux [France] ; François Goldwasser [France] ; Pierre Boutouyrie [France] ; Maureen Alivon [France] ; Koen D. Reesink [Pays-Bas] | Patient-specific blood pressure correction technique for arterial stiffness: evaluation in a cohort on anti-angiogenic medication. |
| 000654 (2017) |
Athmane Bouroubi [France] ; Yves Donazzolo [France] ; Franck Donath [Allemagne] ; Ron Eccles [Royaume-Uni] ; Marc Russo [Australie] ; Nadine Harambillet [France] ; Stéphanie Gautier [France] ; Agnès Montagne [France] | Pain relief of sore throat with a new anti-inflammatory throat lozenge, ibuprofen 25 mg: A randomised, double-blind, placebo-controlled, international phase III study. |
| 000F29 (2017) |
Ai-Hua Jin [Australie] ; Zoltan Dekan [Australie] ; Michael J. Smout [Australie] ; David Wilson [Australie] ; Sébastien Dutertre [Australie] ; Irina Vetter [Australie] ; Richard J. Lewis [Australie] ; Alex Loukas [Australie] ; Norelle L. Daly [Australie] ; Paul F. Alewood [Australie] | Conotoxin Φ-MiXXVIIA from the Superfamily G2 Employs a Novel Cysteine Framework that Mimics Granulin and Displays Anti-Apoptotic Activity. |
| 000F79 (2017) |
Carles Gaig [Espagne] ; Francesc Graus [Espagne] ; Yarko Compta [Espagne] ; Birgit Högl [Espagne] ; Luis Bataller [Espagne] ; Norbert Brüggemann [Espagne] ; Caroline Giordana [Espagne] ; Anna Heidbreder [Espagne] ; Katya Kotschet [Espagne] ; Jan Lewerenz [Espagne] ; Stefan Macher [Espagne] ; Maria J. Martí [Espagne] ; Teresa Montojo [Espagne] ; Jesus Pérez-Pérez [Espagne] ; Inmaculada Puertas [Espagne] ; Caspar Seitz [Espagne] ; Mateus Simabukuro [Espagne] ; Nieves Téllez [Espagne] ; Klaus-Peter Wandinger [Espagne] ; Alex Iranzo [Espagne] ; Guadalupe Ercilla [Espagne] ; Lidia Sabater [Espagne] ; Joan Santamaría [Espagne] ; Josep Dalmau [Espagne] | Clinical manifestations of the anti-IgLON5 disease. |
| 001070 (2017) |
Veronika Matušková [République tchèque] ; Vladimir J. Balcar [Australie] ; Naim A. Khan [France] ; Ond Ej Bonczek [République tchèque] ; Laura Ewerlingová [République tchèque] ; Tomáš Zeman [République tchèque] ; Petr Kolá [République tchèque] ; Daniela Vysloužilová [République tchèque] ; Eva Vlková [République tchèque] ; Omar Šer [République tchèque] | CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: Implications for the safety of the therapy. |
| 001180 (2017) |
Seungyoun Jung [États-Unis] ; Naomi Allen [Royaume-Uni] ; Alan A. Arslan [États-Unis] ; Laura Baglietto [Australie] ; Aurelio Barricarte [Espagne] ; Louise A. Brinton [États-Unis] ; Brian L. Egleston [États-Unis] ; Roni T. Falk [États-Unis] ; Renée T. Fortner [Allemagne] ; Kathy J. Helzlsouer [États-Unis] ; Yutang Gao [République populaire de Chine] ; Annika Idahl [Suède] ; Rudolph Kaaks [Allemagne] ; Vittorio Krogh [Italie] ; Melissa A. Merritt [Royaume-Uni] ; Eva Lundin [Suède] ; N Charlotte Onland-Moret [Pays-Bas] ; Sabina Rinaldi [France] ; Helena Schock [Allemagne] ; Xiao-Ou Shu [États-Unis] ; Patrick M. Sluss [États-Unis] ; Paul N. Staats [États-Unis] ; Carlotta Sacerdote [Italie] ; Ruth C. Travis [Royaume-Uni] ; Anne Tj Nneland [Danemark] ; Antonia Trichopoulou [Grèce] ; Shelley S. Tworoger [États-Unis] ; Kala Visvanathan [États-Unis] ; Elisabete Weiderpass [Norvège] ; Anne Zeleniuch-Jacquotte [États-Unis] ; Joanne F. Dorgan [États-Unis] | Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts. |
| 001181 (2017) |
Séverine Vermeire [Belgique] ; William J. Sandborn [États-Unis] ; Silvio Danese [Italie] ; Xavier Hébuterne [France] ; Bruce A. Salzberg [États-Unis] ; Maria Klopocka [Pologne] ; Dino Tarabar [Serbie] ; Tomas Vanasek [République tchèque] ; Miloš Greguš [Slovaquie] ; Paul A. Hellstern [États-Unis] ; Joo Sung Kim [Corée du Sud] ; Miles P. Sparrow [Australie] ; Kenneth J. Gorelick [États-Unis] ; Michelle Hinz [États-Unis] ; Alaa Ahmad [États-Unis] ; Vivek Pradhan [États-Unis] ; Mina Hassan-Zahraee [États-Unis] ; Robert Clare [États-Unis] ; Fabio Cataldi [États-Unis] ; Walter Reinisch [Canada] | Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial. |
| 001669 (2016) |
B. Bailly [Australie] ; C.-A. Richard [France] ; G. Sharma [Singapour] ; L. Wang ; L. Johansen [États-Unis] ; J. Cao ; V. Pendharkar [Singapour] ; D.-C. Sharma [Singapour] ; M. Galloux [France] ; Y. Wang ; R. Cui ; G. Zou ; P. Guillon [Australie] ; M. Von Itzstein [Australie] ; J.-F. Eléouët [France] ; R. Altmeyer [Australie, Singapour, États-Unis] | Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication |
| 001888 (2016) |
Adil I. Daud [Australie] ; Jedd D. Wolchok [Australie] ; Caroline Robert [Australie] ; Wen-Jen Hwu [Australie] ; Jeffrey S. Weber [Australie] ; Antoni Ribas [Australie] ; F. Stephen Hodi [Australie] ; Anthony M. Joshua [Australie] ; Richard Kefford [Australie] ; Peter Hersey [Australie] ; Richard Joseph [Australie] ; Tara C. Gangadhar [Australie] ; Roxana Dronca [Australie] ; Amita Patnaik [Australie] ; Hassane Zarour [Australie] ; Charlotte Roach [Australie] ; Grant Toland [Australie] ; Jared K. Lunceford [Australie] ; Xiaoyun Nicole Li [Australie] ; Kenneth Emancipator [Australie] ; Marisa Dolled-Filhart [Australie] ; S. Peter Kang [Australie] ; Scot Ebbinghaus [Australie] ; Omid Hamid [Australie] | Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma |
| 001990 (2016) |
Cédric Benoist D Zy [France] ; Bruno Pereira [France] ; Frédéric Chiambaretta [France] ; Frédéric Dutheil [France, Australie] | Oxidative and Anti-Oxidative Stress Markers in Chronic Glaucoma: A Systematic Review and Meta-Analysis |
| 001B02 (2016) |
Y I Deng [Australie] ; Elise Verron [France] ; Ramin Rohanizadeh [Australie] | Molecular Mechanisms of Anti-metastatic Activity of Curcumin. |
| 001C98 (2016) |
Deepak Mittal [Australie] ; Franco Caramia [Australie] ; Stefan Michiels [France] ; Heikki Joensuu [Finlande] ; Pirkko-Liisa Kellokumpu-Lehtinen [Finlande] ; Christos Sotiriou [Belgique] ; Sherene Loi [Australie] ; Mark J. Smyth [Australie] | Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells. |
| 001E20 (2016) |
E K Morgen [Canada] ; H-J Lenz [États-Unis] ; D J Jonker [Canada] ; D. Tu [Canada] ; G. Milano [France] ; F. Graziano [Italie] ; J. Zalcberg [Australie] ; C S Karapetis [Australie] ; A. Dobrovic [Australie] ; C J O'Callaghan [Canada] ; G. Liu [Canada] | Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. |
| 002030 (2016) |
Fabien Bernard Vincent [Australie] ; Stephan Pavy [France] ; Roman Krzysiek [France] ; Thierry Lequerré [France] ; Jérémie Sellam [France] ; Yassine Taoufik [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France] | Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. |
| 002060 (2016) |
Angela C. Baird ; Dominic Mallon ; Graham Radford-Smith ; Julien Boyer ; Thierry Piche ; Susan L. Prescott ; Ian C. Lawrance ; Meri K. Tulic | Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy |
| 002358 (2016) |
Helen Kovari [Suisse] ; Caroline A. Sabin [Royaume-Uni] ; Bruno Ledergerber [Suisse] ; Lene Ryom [Danemark] ; Peter Reiss [Pays-Bas] ; Matthew Law [Australie] ; Christian Pradier [France] ; Francois Dabis ; Antonella D'Arminio Monforte [Italie] ; Colette Smith [Royaume-Uni] ; Stephane De Wit [Belgique] ; Ole Kirk [Danemark] ; Jens D. Lundgren [Danemark] ; Rainer Weber [Suisse] | Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study |
| 002374 (2016) |
Nina Friis-M Ller [Danemark] ; Lene Ryom [Danemark] ; Colette Smith [Royaume-Uni] ; Rainer Weber [Suisse] ; Peter Reiss [Pays-Bas] ; F. Dabis [France] ; Stephane De Wit [Belgique] ; Antonella D'Arminio Monforte [Italie] ; Ole Kirk [Danemark] ; Eric Fontas [France] ; Caroline Sabin [Royaume-Uni] ; Andrew Phillips [Royaume-Uni] ; Jens Lundgren [Danemark] ; Matthew Law [Australie] | An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study. |
| 002778 (2015) |
K Bailey Freund [Suisse] ; Jean-François Korobelnik ; Robert Devenyi ; Carsten Framme ; John Galic ; Edward Herbert ; Hans Hoerauf ; Paolo Lanzetta ; Stephan Michels ; Paul Mitchell ; Jordi Monés ; Carl Regillo ; Ramin Tadayoni ; James Talks ; Sebastian Wolf | TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. |
| 002781 (2015) |
J. Bonneau [France] ; C. Dumestre-Perard [France] ; M. Rinaudo-Gaujous [France] ; C. Genin [France] ; M. Sparrow [Australie] ; X. Roblin [France] ; S. Paul [France] | Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes. |
